These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 23165334)
1. The correlations of LMX1A and osteopontin expression to the clinicopathologic stages in pancreatic adenocarcinoma. Tsai WC; Lin CK; Yang YS; Chan DC; Gao HW; Chang FN; Jin JS Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):395-400. PubMed ID: 23165334 [TBL] [Abstract][Full Text] [Related]
2. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas. Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568 [TBL] [Abstract][Full Text] [Related]
3. LMX1A as a prognostic marker in ovarian mucinous cystadenocarcinoma. Lin CK; Chao TK; Lai HC; Lee HS Am J Clin Pathol; 2012 Jun; 137(6):971-7. PubMed ID: 22586057 [TBL] [Abstract][Full Text] [Related]
4. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia. Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913 [TBL] [Abstract][Full Text] [Related]
5. EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people. Tsai WC; Chao YC; Sheu LF; Lin YF; Nieh S; Chen A; Yu CP; Jin JS APMIS; 2007 Aug; 115(8):929-38. PubMed ID: 17696949 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias. Lisovsky M; Dresser K; Woda B; Mino-Kenudson M Hum Pathol; 2010 Jun; 41(6):902-9. PubMed ID: 20233622 [TBL] [Abstract][Full Text] [Related]
7. Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma. Collins AL; Rock J; Malhotra L; Frankel WL; Bloomston M Ann Surg Oncol; 2012 Aug; 19(8):2673-8. PubMed ID: 22461132 [TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas. Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869 [TBL] [Abstract][Full Text] [Related]
9. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas. Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. Rychlíková J; Vecka M; Jáchymová M; Macášek J; Hrabák P; Zeman M; Vávrová L; Řoupal J; Krechler T; Ák A Cancer Biomark; 2016 Jun; 17(1):55-65. PubMed ID: 27314293 [TBL] [Abstract][Full Text] [Related]
11. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054 [TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas. Sedivy R; Peters K; Klöppel G Virchows Arch; 2005 Jan; 446(1):41-5. PubMed ID: 15568158 [TBL] [Abstract][Full Text] [Related]
13. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters. Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474 [TBL] [Abstract][Full Text] [Related]
14. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504 [TBL] [Abstract][Full Text] [Related]
15. Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas. Evans JD; Cornford PA; Dodson A; Greenhalf W; Foster CS; Neoptolemos JP Pancreatology; 2001; 1(3):254-62. PubMed ID: 12120204 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic Cancer and Osteopontin: The Relationship Remains Unclear. Weber CE; Erşahin ÇH; Kuo PC; Mi Z Pancreas; 2016 Aug; 45(7):e35-6. PubMed ID: 27400159 [No Abstract] [Full Text] [Related]
17. [Clinical implication of BRSK2 expression in pancreatic ductal adenocarcinoma]. Niu GM; Ji Y; Jin DY; Hou J; Lou WH Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1084-8. PubMed ID: 20646422 [TBL] [Abstract][Full Text] [Related]
18. The association of urocortin expression with clinicopathologic parameters of gastric adenocarcinomas. Cheng MF; Tsai WC; Yu-Chieh L; Hsia KT; Jin JS Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):288-94. PubMed ID: 23531852 [TBL] [Abstract][Full Text] [Related]
19. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671 [TBL] [Abstract][Full Text] [Related]
20. Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis. Tsiambas E; Kravvaritis C; Tsounis D; Salemis NS; Niotis A; Niotis TH; Rigopoulos DN; Karameris A; Athanasiou AE; Patsouris E; Karakitsos P J BUON; 2010; 15(1):94-100. PubMed ID: 20414934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]